4//SEC Filing
Ardea Biosciences, Inc./DE 4
Accession 0001209191-12-034769
CIK 0001103390operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 6:46 PM ET
Size
18.9 KB
Accession
0001209191-12-034769
Insider Transaction Report
Form 4
DAVIS STEPHEN
EVP & COO
Transactions
- Disposition to Issuer
Restricted Stock Award
2012-06-19$32.00/sh−11,459$366,688→ 0 totalExercise: $0.00Exp: 2020-04-05→ Common Stock (11,459 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2012-06-19$10.65/sh−18,732$199,496→ 0 totalExercise: $21.35Exp: 2020-04-05→ Common Stock (18,732 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$8.34/sh−80,000$667,200→ 0 totalExercise: $23.66Exp: 2020-12-13→ Common Stock (80,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$10.65/sh−131,268$1,398,004→ 0 totalExercise: $21.35Exp: 2020-04-05→ Common Stock (131,268 underlying) - Disposition to Issuer
Common Stock
2012-06-19$32.00/sh−16,099$515,168→ 0 total - Disposition to Issuer
Incentive Stock Option (right to buy)
2012-06-19$13.06/sh−5,279$68,944→ 0 totalExercise: $18.94Exp: 2021-12-15→ Common Stock (5,279 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$13.06/sh−74,721$975,856→ 0 totalExercise: $18.94Exp: 2021-12-15→ Common Stock (74,721 underlying)
Footnotes (3)
- [F1]Includes 283 shares acquired under the Ardea Biosciences, Inc. ("Ardea") 2000 Employee Stock Purchase Plan on June 12, 2012.
- [F2]This option was canceled pursuant to the Agreement and Plan of Merger, dated as of April 21, 2012, by and among Ardea, Zeneca Inc. and QAM Corp. (the "Merger Agreement"), in exchange for a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) the excess of $32.00 (the per share merger consideration pursuant to the Merger Agreement) over the exercise price of the option; and (ii) the number of shares of Ardea common stock underlying the option.
- [F3]This restricted stock award was canceled pursuant to the Merger Agreement in exchange for a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) $32.00 (the per share merger consideration pursuant to the Merger Agreement); and (ii) the number of shares of Ardea common stock subject to the restricted stock award.
Documents
Issuer
Ardea Biosciences, Inc./DE
CIK 0001103390
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001103390
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 6:46 PM ET
- Size
- 18.9 KB